One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention-Reference-Cited by-同舟云学术

One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Published:2023-10 Issue:10 Volume:17 Page:102858
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Li Yulong,Li Jiawen,Guan Changdong,Su Shuhong,Wang Zhifang,Liu Haiwei,Yang Yuejin,Gao Runlin,Yuan Jinqing,Zhao Xueyan^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. ESC Guidelines for the management of cardiovascular disease in patients with diabetes [J];Marx;Eur Heart J,2023

2. Assessing cardiovascular risk in patients with diabetes: an update [J];Damaskos;Curr Cardiol Rev,2020

3. Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty

4. Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial [J];Feit;J Am Coll Cardiol,2008

5. Diabetes mellitus and thrombosis [J];Vazzana;Thromb Res,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-29